Retatrutide 40mg Research Pen Kit (Triple Agonist R&D Formulation)
Overview
The Retatrutide 40mg Research Pen Kit is an advanced laboratory formulation designed for metabolic pathway research, receptor-binding studies, and peptide stability testing. Retatrutide is a novel triple agonist peptide that mimics the activity of three natural hormone receptors: GLP-1, GIP, and glucagon.
This comprehensive R&D kit provides researchers with a precise, ready-to-use format for conducting in-vitro dose-response assays, formulation development, and biochemical analysis in a controlled laboratory environment.
Important Research Notice: This product is supplied strictly as a research and development (R&D) formulation kit. It is intended solely for in-vitro laboratory testing and biochemical analysis. It is not intended for human or veterinary consumption, injection, weight management, or any clinical application.
What Is in the Retatrutide 40mg Research Kit?
This kit is designed to provide laboratories with everything needed for precise peptide aliquoting and formulation testing:
- ✅ 1 x Retatrutide Research Pen: Contains 40mg total active peptide content.
- ✅ 12 x Disposable Laboratory Needles: Provided strictly for in-vitro dispensing, aliquoting, and formulation testing.
- ✅ 1 x R&D Handling & Formulation Booklet: Contains laboratory safety protocols, storage guidelines, and handling instructions.
Laboratory Aliquoting & Modeling:
The 40mg total content allows researchers to model various concentration gradients (e.g., 2.5mg, 5mg, 7.5mg, or 10mg equivalents) for in-vitro dose-response assays and formulation stability testing. Note: These figures represent laboratory modeling increments for experimental design, not human dosing recommendations.
The 40mg total content allows researchers to model various concentration gradients (e.g., 2.5mg, 5mg, 7.5mg, or 10mg equivalents) for in-vitro dose-response assays and formulation stability testing. Note: These figures represent laboratory modeling increments for experimental design, not human dosing recommendations.
Suitable R&D & Laboratory Applications
The Retatrutide 40mg kit is specifically engineered to support a wide range of non-clinical, laboratory-based research objectives:
- 🧪 Stability Testing: Conduct thermal, enzymatic, and oxidative degradation studies, alongside shelf-life evaluation and formulation robustness testing for triple-agonist peptides.
- ⚗️ Formulation Development: Research methods to enhance solubility, bioavailability, and structural integrity for research-grade delivery models.
- 🧩 Excipient Compatibility Testing: Evaluate interactions between the active retatrutide peptide and various inactive components, buffers, or preservatives to ensure long-term formulation stability. (Note: Corrected from original draft to provide accurate, distinct scientific value).
- 🔒 Protease Resistance Evaluation: Assess peptide stability and interactions when exposed to enzymatic degradation in simulated biological environments.
- 💊 Encapsulation & Carrier Systems: Develop and test liposomes, microspheres, and other advanced delivery vehicles to protect peptides and enable controlled release in laboratory models.
- 🛤️ Administration Route Assessment: Perform in-vitro modeling of parenteral delivery mechanisms and dermal absorption rates for research applications.
Product Specifications
|
Specification
|
Detail
|
|---|---|
|
Product Name
|
Retatrutide 40mg Research Pen Kit
|
|
Active Compound
|
Retatrutide (Triple Agonist: GLP-1 / GIP / Glucagon)
|
|
Total Content
|
40mg per pen
|
|
Format
|
Pre-formulated research pen with laboratory dispensing accessories
|
|
Included Accessories
|
12 x sterile laboratory dispensing needles, 1 x R&D booklet
|
|
Intended Application
|
Laboratory R&D, metabolic pathway research, and biochemical analysis only
|
|
Human/Veterinary Use
|
Strictly not intended for human or veterinary use
|
Quality Assurance & Laboratory Handling
Proper handling is critical to maintaining the integrity of peptide formulations during the research process:
- Storage: Store the research pen at 2–8°C (refrigerated), protected from direct light and moisture. Do not freeze.
- Inspection: Inspect the pen and seals before laboratory use. Do not use if the packaging is compromised, the vacuum is lost, or the solution appears discolored or contains particulate matter.
- Dispensing: The included needles are provided strictly for laboratory dispensing, aliquoting, and formulation testing. They must not be used on humans or animals.
- Documentation: Always refer to the supplied R&D instruction booklet for specific handling, laboratory modeling, and safety protocols.
UK Shipping & Delivery
Orders placed before 15:00 GMT on a working day are dispatched the same day from our UK facility. We use secure, discreet packaging to ensure your research materials arrive safely.
- UK Tracked Delivery: 1–2 working days · from £4.95
- International Shipping: Calculated at checkout based on destination and customs requirements.
Frequently Asked Questions (FAQ)
(Optimized for Google’s “People Also Ask” featured snippets)
What is the Retatrutide 40mg Research Pen Kit?
It is an advanced laboratory formulation kit containing 40mg of the triple-agonist peptide Retatrutide, along with dispensing needles and an R&D booklet, designed for metabolic pathway research and peptide stability testing.
It is an advanced laboratory formulation kit containing 40mg of the triple-agonist peptide Retatrutide, along with dispensing needles and an R&D booklet, designed for metabolic pathway research and peptide stability testing.
Is this kit used for weight loss?
No. While retatrutide is studied in clinical trials for metabolic effects, this specific product is supplied strictly for in-vitro laboratory research, biochemical analysis, and formulation development. It is not a weight loss medication and is not for human consumption.
No. While retatrutide is studied in clinical trials for metabolic effects, this specific product is supplied strictly for in-vitro laboratory research, biochemical analysis, and formulation development. It is not a weight loss medication and is not for human consumption.
What are the “doses” mentioned in the booklet?
The references to 2.5mg, 5mg, 7.5mg, or 10mg are strictly for laboratory modeling and aliquoting. They represent concentration gradients researchers can draw from the 40mg total vial to create specific in-vitro dose-response assays, not human dosing schedules.
The references to 2.5mg, 5mg, 7.5mg, or 10mg are strictly for laboratory modeling and aliquoting. They represent concentration gradients researchers can draw from the 40mg total vial to create specific in-vitro dose-response assays, not human dosing schedules.
What R&D applications is this kit suitable for?
It is ideal for stability testing, formulation development, excipient compatibility testing, protease resistance evaluation, and encapsulation research.
It is ideal for stability testing, formulation development, excipient compatibility testing, protease resistance evaluation, and encapsulation research.
Are the included needles for human injection?
Absolutely not. The 12 disposable needles are provided strictly for laboratory dispensing, aliquoting, and in-vitro formulation testing. This product is not for human or veterinary use.
Absolutely not. The 12 disposable needles are provided strictly for laboratory dispensing, aliquoting, and in-vitro formulation testing. This product is not for human or veterinary use.
How should the Retatrutide research pen be stored?
The pen should be stored refrigerated at 2–8°C, protected from direct light and moisture, in accordance with standard laboratory peptide handling protocols.
The pen should be stored refrigerated at 2–8°C, protected from direct light and moisture, in accordance with standard laboratory peptide handling protocols.
Research Use Only Disclaimer
The Retatrutide 40mg Research Pen Kit supplied by Retatrutide Pen is intended strictly for laboratory research, R&D formulation testing, and biochemical analysis. It is not intended for human or veterinary use, consumption, injection, weight management, diagnosis, treatment, or any clinical application. Researchers and laboratories are solely responsible for ensuring that the material is handled, tested, and disposed of in accordance with their own institutional safety procedures and applicable regulatory requirements.






Reviews
There are no reviews yet.